aTYR PHARMA INC
ATYR· Nasdaq
ATYRaTYR PHARMA INC
Filed May 15, 2018 · 10-Q · 45 days after period end · 0001564590-18-013628
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Net Income | -$10.67M | -$13.41M | -$16.09M | -$9.07M |
| EPS Diluted | -$5.01 | -$0.56 | -$0.68 | -$9.39 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
aTYR PHARMA INC · CIK 1339970 · Engraved from SEC EDGAR
ended Mar 31, 2018 · filed May 15, 2018 · 45 d after period end
